The global liver cancer drugs market is projected to reach USD 2,332 million by 2032, up from USD 980 million in 2022. This reflects a strong CAGR of 9.3% from 2023 to 2032. One of the major drivers of this growth is the rising global incidence of liver cancer. According to the World Health Organization (WHO), liver cancer was responsible for over 800,000 deaths in 2022. It ranks as the third...